Board Of Directors

WORK EXPERIENCE

Mr. Ho is the Executive Chairman of Keck Seng (Malaysia) Berhad since 1970 and also of Keck Seng Investments (Hong Kong) Limited since 1979. He is also a Non-Executive Director of Shangri-la Asia Limited since 1993 and a member of its Audit Committee. He was previously the Director of Parkway Holdings Limited/Parkway Pantai Limited from 1985 to 2013 and was the Chairman of the Tender Committee.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Business Administration and Commerce

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Executive Chairman of Keck Seng Investments (Hong Kong) Limited
• Executive Chairman of Keck Seng (Malaysia) Berhad

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Non-Executive Director of Shangri-la Asia Limited

WORK EXPERIENCE

Dr. Lee serves on the boards of Parkway Trust Management Ltd and The Esplanade Company Ltd. Dr. Lee was the Chief Executive Officer (CEO) of KK Women’s and Children’s Hospital from 1991 to 2004. Before joining KK Hospital, she was the Chief Operating Officer of Singapore General Hospital from 1988 to 1991 during the period of its corporatisation, and prior to that served in the Ministry of Health in various portfolios. Her most recent work has been in development of the ageing sector, as Senior Consultant with the Ministry of Health’s Ageing Planning Office from 2007 to 2015 and Chairperson of the Agency for Integrated Care from 2009 to 2018.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• MBBS, National University of Singapore
• MBA, National University of Singapore

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Director of Guangzhou ZhongXing RenHui International Medical Management Company Ltd

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Director of Ministry of Health Holdings
• Chairman of Agency for Integrated Care Pte Ltd
• Director of The Esplanade Co Ltd

WORK EXPERIENCE

Ms. Cheah serves as Executive Board Chair of privately held ESG startup ecoSPIRITS and sits on the boards of several publicly-listed companies in Singapore. She is also Operating Partner at Wavemaker Partners, a tech-focused venture capital fund dual headquartered in Singapore and Los Angeles.

She previously spent more than 20 years in the investment banking industry. She started her career with Merrill Lynch New York, followed by stints in Singapore and London. Subsequently, she became Executive Director of Investment Banking at JP Morgan Singapore and later served as Co-head of Corporate Finance SEA at BNP Paribas.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• BA, Economics and French, Wellesley College, Massachusetts, USA

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Executive Board Chair, ecoSPIRITS Pte Ltd
• Independent Non-Executive Director of Pathology Asia Holdings Pte Ltd ( also Chairman of Audit Committee)
• Independent Non-Executive Director of TeleChoice International Limited (also Member of Audit Committee)
• Independent Non-Executive Director of M&C REIT Management Limited (also Member of Nominating and Remuneration Committee)
• Independent Non-Executive Director of M&C Business Trust Management Limited
• Operating Partner of Wavemaker Partners

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Nil

WORK EXPERIENCE

Dr. Loh was appointed Chief Executive Officer (Designate) and Executive Director of IHH Healthcare on 1 July 2019 and assumed the position as its Managing Director and Chief Executive Officer on 1 January 2020. He provides strategic direction and leadership for overall operations within IHH and its key operating subsidiaries – Parkway Pantai, Acibadem Healthcare, Fortis Healthcare and IMU Health. Today, IHH Healthcare offers a full spectrum of integrated services with a strong stable of 80 hospitals and more than 15,000 licensed beds in 10 countries.

An experienced healthcare executive with strong track record of delivery, Dr. Loh has extensive experience in leading large healthcare businesses, building relationships with stakeholders, managing hospital operations, financial management and developing people. He is also deeply familiar with the healthcare operating context in different countries across Asia.

Prior to joining IHH Healthcare, Dr. Loh was with Columbia Asia Group, where he oversaw its healthcare business comprising 28 hospitals across four countries in Asia as Chief Executive Officer since 2017.

Dr. Loh spent the early years of his career as a practising general physician. Driven by a passion for healthcare systems improvement, he embarked on the management track in the public healthcare sector and widened his healthcare portfolios to include clinical services development, hospital planning and hospital management. In 2008, he joined IHH Healthcare where he served nine years in numerous senior management roles, including as Chief Executive Officer of Singapore Operations Division where he steered the group’s integrated healthcare businesses in Singapore.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Master Degree in Business Administration, National University of Singapore, Business School
• Bachelor of Medicine and Bachelor of Surgery, National University of Singapore

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Managing Director and Chief Executive Officer of IHH Healthcare Berhad
• Managing Director and Chief Executive Officer of Parkway Pantai Limited
• Non-Executive and Non-Independent Director of Fortis Healthcare Limited
• Executive Director and Managing Director of Parkway Holdings Ltd
• Director of SRL Limited
• Director of Acibadem Saglik Yatirimlari Holding A.S.
• Director of GHK Hospital Limited

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Chief Executive Officer (Designate) and Executive Director of IHH Healthcare Berhad
• Group Chief Executive Officer of Columbia Asia Group of Companies

WORK EXPERIENCE

Appointed to the Board of IHH Healthcare Berhad in 2019, Mr Takeshi Saito was an alternate director to Mr Satoshi Tanaka and Mr Koji Nagatomi, during their tenure as Directors of IHH between June 2015 and March 2019. He also serves on the Boards of a few IHH subsidiaries. Mr Saito currently serves as Chief Executive Officer of MBK Healthcare Management Pte Ltd (MHM), a wholly-owned subsidiary of Mitsui & Co., Ltd (Mitsui) based in Singapore, which manages the healthcare assets within the portfolio of Mitsui.

Preceding his appointment as CEO of MHM, he served as General Manager of Healthcare Business 1st Department in Healthcare Business Division of Mitsui. In 2017, he was an Executive Assistant to a Representative Director and Executive Vice President of Mitsui. Between 2015 and 2016, he was the General Manager of the Provider Network Department, Medical Healthcare Business Division 1, Consumer Service Business Unit of Mitsui and also sat on the Board and Executive Committee of Parkway Pantai Limited, a wholly-owned subsidiary of IHH, as an alternate director. In 2011, Mr Saito was seconded to Parkway Group Healthcare as Vice President of Strategic Planning, following his appointment as Director of the Medical Healthcare Business Department at Mitsui, where he led the investment in IHH.

Prior to this in 2007, Mr Saito was appointed Manager of the Strategic Planning/Business Development Department of the Life Science Division at Mitsui, which subsequently became the Medical Healthcare Division in 2008.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Bachelor of Political Science, Keio University, Japan
• Master of Business Administration, Kellogg School of Management, Northwestern University

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Director and Chief Executive Officer of MBK Healthcare Management Pte Ltd
• Non-Executive Director of IHH Healthcare Berhad
• Non-Executive Director of Fortis Healthcare Limited
• Non-Executive Director of Acibadem Saglik Yatirimlari Holding A.S. and Acibadem Saglik Hizmetleri ve Ticaret A.S.

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Non-Executive Director of Acibadem Proje Yonetimi A.S.
• Non-Executive Director of Aplus Hastane Otelcilik Hizmetleri A.S.

WORK EXPERIENCE

Mr. Sim was appointed as Group Chief Operating Officer of IHH Healthcare on 1 January 2020.

He has more than 19 years’ experience in the healthcare industry and was the winner of the Leading CEO Award by Singapore Human Resources Institute in 2014. Prior to joining Parkway Pantai in June 2017, he was Group Deputy Chief Executive of National University Healthcare System in Singapore and concurrently the Chief Operating Officer and Chief Executive Officer of National University Hospital. He also held the roles of Chief Corporate Development Officer, acting Chief Information Officer and acting Chief Executive Officer for new ventures at the National Healthcare Group in Singapore.

Mr. Sim began his career with the Singapore Administrative Service, building up a robust portfolio at the Ministry of Finance, Community Development Council and Ministry of Defence. In 2000, he founded a company that developed business-to-business trading hubs before joining the private sector where he was responsible for developing thought leadership, concepts and innovation on next-generation revenue agency for Accenture. Between 2008 and 2015, Mr. Sim was an Adjunct Lecturer at Nanyang Business School, during which he was recognised with a Teacher of the Year Award. He was also an Adjunct Associate Professor at the National University of Singapore’s School of Public Health and Business School before he joined Parkway Pantai.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Bachelor of Arts in Electronic and Information Science Tripos, University of Cambridge
• Masters in Public Administration, Kennedy School of Government, Harvard University

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Director of Fortis Healthcare Limited
• Group Chief Operating Officer of IHH Healthcare Berhad
• Committee Member of Nanyang Business School Advisory Board
• Chairman of Health Sciences Advisory Committee of Ngee Ann Polytechnic

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Chief Executive Officer of Parkway Pantai Limited, Malaysia Operations Division

WORK EXPERIENCE

Mr. Ayrle was appointed the Group Chief Financial Officer (GCFO) of IHH Healthcare Berhad (IHH) on 1 February 2021. With a wealth of international experience from United States, Germany, Singapore, China and Thailand, he will be responsible for providing financial leadership and strategic guidance for IHH and its operations and the business plan development. In his role, Mr. Ayrle will ensure effective management of resources, safeguard shareholders’ interests and steer financial and management reporting, treasury, tax and investor relations functions and support the companies M&A activities.

Prior to joining IHH, Mr. Ayrle was the GCFO of Thai Union Group PLC and steered the Company’s financial transformation journey, winning multiple awards including Best CFO Asia by Corporate Treasurer in 2016.

He also had a successful career with tech giants Osram and Siemens. Most notably, he was Chief Financial Officer & Treasurer of Osram Sylvania, USA, and Managing Director of Corporate Finance Mergers, Acquisitions & Post Closing (ASIA) for Siemens, China.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• Masters of Business Administration major in Finance & Controlling, Marketing, Finance-Mathematics, University of Augsburg, Germany
• Certified fellow of the Institute of Directors, Thailand
• Advisory Professor, Tongji University, Shanghai, China

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• IHH Healthcare Berhad, Group Chief Financial Officer

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Thai Union Group PCL, Group Chief Financial Officer, Member of the Executive Committee, Member of the Risk Management Committee
• Red Lobster Master Holdings GP, LLC, President
• Thai Union Europe SAS, Director, Chairman of the Audit Committee
• King Oscar AS, Chairman of the Board of Directors
• Rügen Fisch AG, Chairman of the Supervisory Committee
• Thai Union China Co., Ltd, Director and Shareholder Representative
• Thamachart Seafood Retail Co., Ltd, Director
• Thai Union Ingredients Company Ltd., Director

WORK EXPERIENCE

Mr. Yong is the CEO and Executive Director of Parkway Trust Management Limited, the Manager of Parkway Life REIT.

Since Parkway Life REIT's listing in 2007, Mr. Yong has grown the REIT's portfolio, which more than doubled to over S$2 billion in assets now. PLife REIT has also consistently delivered, with Distributions Per Unit for FY2021 122.8% higher since listing. With his leadership, PLife REIT was included in the FTSE EPRA NAREIT Global Developed Index in 2020. The index inclusion affirms the REIT's strong position as one of the largest listed healthcare REITs in Asia and enhances its trading liquidity and visibility to investors and index funds worldwide.

Mr. Yong’s deep expertise in finance and corporate strategy is attributed to his prior work experience as the CFO of the Singapore Tourism Board, overseeing its finance and corporate services functions. Prior to that, he was the CFO of Ascendas Pte Ltd (Ascendas). During his tenure with Ascendas, he was seconded to China-Singapore Suzhou Development Ltd and Singapore-Suzhou Township Development Pte Ltd as their CFO in Suzhou, China. Before joining Ascendas, Mr. Yong held other finance and audit positions at Beijing ISS International School, Housing and Development Board and Arthur Andersen.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

• B.ACC (Hons), Fellow Chartered Accountant of Singapore
• Advanced Management Programme with Harvard Business School

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

• Nil

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

• Nil